Cargando…

2023 Chinese guideline for lipid management

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death among urban and rural residents in China, and elevated low-density lipoprotein cholesterol (LDL-C) is a risk factor for ASCVD. Considering the increasing burden of ASCVD, lipid management is of the utmost importance. In rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jian-Jun, Zhao, Shui-Ping, Zhao, Dong, Lu, Guo-Ping, Peng, Dao-Quan, Liu, Jing, Chen, Zhen-Yue, Guo, Yuan-Lin, Wu, Na-Qiong, Yan, Sheng-Kai, Wang, Zeng-Wu, Gao, Run-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498001/ https://www.ncbi.nlm.nih.gov/pubmed/37711173 http://dx.doi.org/10.3389/fphar.2023.1190934

Ejemplares similares

Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis
por: Lin, Na, et al.
Publicado: (2021)

The Role of Chinese Herbal Therapy in Methamphetamine Abuse and its Induced Psychiatric Symptoms
por: Chen, Lin, et al.
Publicado: (2021)

Amendment of the low-density lipoprotein cholesterol target in the ‘Chinese Guidelines for the Prevention and Treatment of Adult Dyslipidemia’: Opinion
por: Zhao, Shui-Ping
Publicado: (2016)

A Comprehensive Strategy to Evaluate Compatible Stability of Chinese Medicine Injection and Infusion Solutions Based on Chemical Analysis and Bioactivity Assay
por: Li, Jian-Ping, et al.
Publicado: (2017)

Developmental Pharmacogenetics of CYP2D6 in Chinese Children: Loratadine as a Substrate Drug
por: Li, Qian, et al.
Publicado: (2021)

Adjuvant effects of Chinese medicinal tonics on gastric, liver, and colorectal cancers—OMICs-based contributions to understanding their mechanism of action
por: Zuo, Zhigang, et al.
Publicado: (2022)

D-4F Ameliorates Contrast Media–Induced Oxidative Injuries in Endothelial Cells via the AMPK/PKC Pathway
por: Guo, Yansong, et al.
Publicado: (2021)

Intestinal flora: A new target for traditional Chinese medicine to improve lipid metabolism disorders
por: Liu, Min, et al.
Publicado: (2023)

The alleviating effect of Scutellaria amoena extract on the regulation of gut microbiota and its metabolites in NASH rats by inhibiting the NLRP3/ASC/caspase-1 axis
por: Lin, Yu-Ping, et al.
Publicado: (2023)

Chemical Antioxidant Quality Markers of Chrysanthemum morifolium Using a Spectrum-Effect Approach
por: Lu, Yi-Fan, et al.
Publicado: (2022)

High-Throughput Metabolomics Method for Discovering Metabolic Biomarkers and Pathways to Reveal Effects and Molecular Mechanism of Ethanol Extract From Epimedium Against Osteoporosis
por: Zhao, Jun-feng, et al.
Publicado: (2020)

Management of Ventilator-Associated Pneumonia: Quality Assessment of Clinical Practice Guidelines and Variations in Recommendations on Drug Therapy for Prevention and Treatment
por: Li, Hong-Yan, et al.
Publicado: (2022)

Clinical Progress on Management of Pneumonia Due to COVID-19 With Chinese Traditional Patent Medicines
por: Wu, Ying, et al.
Publicado: (2021)

Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis
por: Ren, Chunzhen, et al.
Publicado: (2022)

Evidence synthesis of Chinese medicine for monkeypox: Suggestions from other contagious pox-like viral diseases
por: Rong, Hong-guo, et al.
Publicado: (2023)

Traditional Chinese Medicine Regulating Lymphangiogenesis: A Literature Review
por: Peng, Longping, et al.
Publicado: (2020)

2023 MERIT Guidelines
por: Stappers, Sara
Publicado: (2022)

Modulatory Effects of Chinese Herbal Medicines on Energy Metabolism in Ischemic Heart Diseases
por: Li, Fanghe, et al.
Publicado: (2020)

Artemisinin: A Panacea Eligible for Unrestrictive Use?
por: Yuan, Dong-Sheng, et al.
Publicado: (2017)

The Effect of Chinese Medicine on Lipid and Glucose Metabolism in Acute Myocardial Infarction Through PPARγ Pathway
por: Zhang, Qian, et al.
Publicado: (2018)

Therapeutic mechanism and clinical application of Chinese herbal medicine against diabetic kidney disease
por: Chen, Dan-Qian, et al.
Publicado: (2022)

Chinese guidelines on intraoperative neuromonitoring in thyroid and parathyroid surgery (2023 edition)
por: Sun, Hui, et al.
Publicado: (2023)

In silico Identification and Mechanism Exploration of Hepatotoxic Ingredients in Traditional Chinese Medicine
por: Wu, Qihui, et al.
Publicado: (2019)

IBD Subtype-Regulators IFNG and GBP5 Identified by Causal Inference Drive More Intense Innate Immunity and Inflammatory Responses in CD Than Those in UC
por: Gao, Sheng, et al.
Publicado: (2022)

Mechanism and Basis of Traditional Chinese Medicine Against Obesity: Prevention and Treatment Strategies
por: Zhang, Chang-hua, et al.
Publicado: (2021)

Treatment of COVID-19 in Hemodialysis Patients Using Traditional Chinese Medicine: A Single-Center, Retrospective Study
por: Huang, Wei, et al.
Publicado: (2022)

The Traditional Chinese Medicine Fuyou Formula Alleviates Precocious Puberty by Inhibiting GPR54/GnRH in the Hypothalamus
por: Bai, Guo-liang, et al.
Publicado: (2021)

Comparison on different traditional Chinese medicine therapies for chronic hepatitis B liver fibrosis
por: Dai, Yun-kai, et al.
Publicado: (2022)

Relationship Between Linezolid Exposure and the Typical Clinical Laboratory Safety and Bacterial Clearance in Chinese Pediatric Patients
por: Huo, Ben-Nian, et al.
Publicado: (2022)

Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro
por: Zou, Li-Li, et al.
Publicado: (2023)

Celastrol Attenuates Lipid Accumulation and Stemness of Clear Cell Renal Cell Carcinoma via CAV-1/LOX-1 Pathway
por: Zhang, Chan-Juan, et al.
Publicado: (2021)

Antifungal Mechanisms of a Chinese Herbal Medicine, Cao Huang Gui Xiang, Against Candida Species
por: Yue, Huizhen, et al.
Publicado: (2022)

Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants
por: Zhao, Yang, et al.
Publicado: (2020)

The Anti-Obesity Effect of Traditional Chinese Medicine on Lipid Metabolism
por: Fan, Qijing, et al.
Publicado: (2021)

Exploration on the Approaches of Diverse Sedimentations in Polyphenol Solutions: An Integrated Chain of Evidence Based on the Physical Phase, Chemical Profile, and Sediment Elements
por: Huang, Hao-zhou, et al.
Publicado: (2019)

Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Chinese Patients With MDR and XDR Nosocomial Pneumonia
por: Zeng, Huihui, et al.
Publicado: (2021)

Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C9*72-*75 in the Chinese Han population
por: Zhao, Fang-Ling, et al.
Publicado: (2022)

Corrigendum: Antifungal mechanisms of a Chinese herbal medicine, Cao Huang Gui Xiang, against Candida species
por: Yue, Huizhen, et al.
Publicado: (2022)

Mitochondrial toxicity evaluation of traditional Chinese medicine injections with a dual in vitro approach
por: Shen, Yunfu, et al.
Publicado: (2022)

Detection of Emodin Derived Glutathione Adduct in Normal Rats Administered with Large Dosage of Polygoni Multiflori Radix
por: Jiang, Li-Long, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_544eq4rvga5ipi8stm1ea234ph